Dr. Holger Bengs

Dr. Holger Bengs – Biotech Consulting, founded in 2002 in Frankfurt / Main, Germany, is specialized in consulting medium-sized companies and non-profit organisations within the field of biotechnology, chemistry, nanotechnology and pharmacy. The company is focused on Marketing Intelligence and has broad experience in public relations, marketing, event management and sponsoring.

Most of its ten employees have an academic education in bio-chemistry, biology, chemistry or molecular genetics. Holger Bengs studied chemistry in Hannover and graduated in Mainz. At the Virtual University Hagen, he did a second degree in business administration with the focus on marketing.

Holger gathered his first professional experiences in the R&D department of Hoechst and Aventis focusing on biologically degradable polymers for drug delivery systems and functional food applications. Later, he has been working for four years as project manager biocatalysis. During this time his team successfully has registered 25 patents.

Then, as founder and Managing Director of Biotech Media GmbH, a subsidiary of Going Public Media AG, Holger was responsible for the coverage of the biotech industry in the stock market publications “GoingPublic” and “Venture Capital Magazin”. Since then the “GoingPublic” special edition on biotechnology is published every year in September. Holger Bengs is the author of the books “Investieren in Biotechnologie – simplified” (2008) and “Mit Biotechnologie zum Börsenerfolg” (2000).